
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
B
BDX
Becton, Dickinson and Company
$167.12
-2.82 (-1.66%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$167.12
Live market price
P/E (TTM)
27.26
EPS: $6.13
P/S (TTM)
2.17
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:56:16 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
14.6M
% of Float
5.1%
Days to Cover
3.8
Avg Daily Vol
3.9M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.82
Leverage ratio
ROE (TTM)
6.95%
Return on equity
Income Statement
Revenue
$5.25B
Cost of Revenue
$2.84B
Gross Profit
$2.41B
Operating Income
$552.00M
Net Income
$382.00M
EPS (Quarter)
$1.34
EPS (TTM)
$6.13
Balance Sheet
Total Assets
$54.84B
Total Liabilities
$29.56B
Shareholders' Equity
$25.28B
Current Assets
$9.19B
Current Liabilities
$8.76B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$657.00M
Investing Cash Flow
$-183.00M
Financing Cash Flow
$-302.00M
Free Cash Flow
$474.00M
Profitability Margins
Gross Margin
45.91%
Operating Margin
10.51%
Net Profit Margin
7.27%
ROA (TTM)
3.20%
ROE (TTM)
6.95%
Data source: Polygon.io
Last updated: 3/8/2026, 5:56:16 AM
Company Profile
Symbol
BDX
Market Cap
$47.54B
IPO Date
Sep 25, 1963
CEO
--
Employees
72,000
Sector
--
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Country
United States
Exchange
--
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
Read MoreSimilar Stocks
TMO
Thermo Fisher Scientific Inc.
$501.97
-3.25%